{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:45:53Z","timestamp":1773398753987,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024144","name":"Bears Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024144","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21CA229707"],"award-info":[{"award-number":["1R21CA229707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01CA260399"],"award-info":[{"award-number":["5R01CA260399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ygyno.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:02:21Z","timestamp":1713484941000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma"],"prefix":"10.1016","volume":"186","author":[{"given":"Gustavo C.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Yozwiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Helen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahyoung Amy","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Watkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2024.04.007_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2024.04.007_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian Cancer treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0020","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) Cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0030","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.5891","article-title":"Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention","volume":"257","author":"Yoon","year":"2022","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.04.007_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.5145","article-title":"Evidence for lineage continuity between early serous proliferations (ESPs) in the fallopian tube and disseminated high-grade serous carcinomas","volume":"246","author":"Soong","year":"2018","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.04.007_bb0060","doi-asserted-by":"crossref","first-page":"076001","DOI":"10.1117\/1.JBO.26.7.076001","article-title":"Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes","volume":"26","author":"Cordova","year":"2021","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0065","first-page":"397","article-title":"Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes","volume":"20","author":"Bartels","year":"1998","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0070","first-page":"63","article-title":"Malignancy associated changes in lactiferous duct epithelium","volume":"25","author":"Anderson","year":"2003","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2005.07.002","article-title":"Karyometry in the early detection and chemoprevention of intraepithelial lesions","volume":"41","author":"Ranger-Moore","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0046-8177(03)00341-1","article-title":"Sub-visual chromatin changes are detected in the histologically normal urothelium in patients with synchronous papillary carcinoma","volume":"34","author":"Montironi","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0085","first-page":"257","article-title":"Cytomorphometric markers for uterine cancer in intermediate cells","volume":"2","author":"Wied","year":"1980","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0090","first-page":"62","article-title":"Malignancy associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal appearing tissue adjacent to cancer","volume":"17","author":"Susnik","year":"1995","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0095","first-page":"159","article-title":"Karyometric features in nuclei near colonic adenocarcinoma. Statistical analysis","volume":"13","author":"Montag","year":"1991","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/1055-9965.EPI-04-0212","article-title":"Exploratory study of ovarian intraepithelial neoplasia","volume":"14","author":"Brewer","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.ygyno.2024.04.007_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1940-6207.CAPR-18-0383","article-title":"Phase II trial of chemopreventive effects of levonorgestrel on ovarian and fallopian tube epithelium in women at high risk for ovarian cancer: an NRG oncology group\/GOG study","volume":"12","author":"Rodriguez","year":"2019","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0110","series-title":"Analytical and Quantitative Cytopathology and Histology","first-page":"44","article-title":"Karyometry identifies a distinguishing fallopian tube epithelium phenotype in subjects at high risk of ovarian cancer","volume":"43","author":"Russel","year":"2021"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0115","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2005.07.002","article-title":"Karyometry in the early detection and chemoprevention of intraepithelial lesions","volume":"41","author":"Ranger-Moore","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0120","first-page":"83","article-title":"Automatic segmentation of cell nuclei in bladder and skin tissue for karyometric analysis","volume":"31","author":"Korde","year":"2009","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.ygyno.2024.04.007_bb0125","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/1940-6207.CAPR-10-0404","article-title":"Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma","volume":"4","author":"Glazer","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2024.04.007_bb0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"issue":"10022","key":"10.1016\/j.ygyno.2024.04.007_bb0135","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2024.04.007_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2021.10.083","article-title":"A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: a window into the abdomen","volume":"164","author":"Rocconi","year":"2022","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T22:00:10Z","timestamp":1727820010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":28,"alternative-id":["S0090825824001926"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}